Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
5 Results Found
DEA and HHS Extend Waivers for Prescribing Controlled Substances Through Telemedicine
The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Dec. 30 released a temporary rule extending for the fourth time waiver flexibilities for prescribing controlled substances via telemedicine.
Trump Administration Issues Order on Drug Pricing
The White House April 15 released an executive order, “Lowering Drug Prices by Once Again Putting Americans First,” directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription drugs.
Fact Sheet: 340B Drug Pricing Program Contract Pharmacy Arrangements
Section 340B of the Public Health Service Act requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at discounted prices to health care organizations that care for patients in vulnerable communities.
AHA Comments on CMS Proposed Medicare Drug Pricing Model
AHA comments regarding the Centers for Medicare & Medicaid Services Medicare $2 Drug List (M2DL) Model request for information (RFI).
Fact Sheet: AHA Priorities for Budget Reconciliation Package to Support America’s Hospitals and Health Systems
It is imperative that Congress invest in America’s hospitals and health systems to ensure
that the nation’s health care needs can be met today and into the future. The AHA supports
investments in infrastructure, such as the health care workforce, behavioral health, the
accessibility and affordability of health care coverage, emergency preparedness and the health
care supply chain, telehealth and cybersecurity, among other areas.